John J. Kirby is Interim CFO of Verrica Pharmaceuticals Inc.. Currently has a direct ownership of 18,962 shares of VRCA, which is worth approximately $150,747. The most recent transaction as insider was on Dec 23, 2025, when has been sold 10,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19K
65.06% 3M change
65.06% 12M change
Total Value Held $150,747

John J. Kirby Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 23 2025
BUY
Grant, award, or other acquisition
-
10,000 Added 34.53%
18,962 Common Stock
Nov 25 2025
BUY
Open market or private purchase
$14,992 $4.24 p/Share
3,536 Added 28.29%
8,962 Common Stock
Nov 06 2024
BUY
Grant, award, or other acquisition
-
54,267 Added 50.0%
54,267 Common Stock

Also insider at

IDRA
IDERA PHARMACEUTICALS, INC. Healthcare
JJK

John J. Kirby

Interim CFO
Exton, PA

Track Institutional and Insider Activities on VRCA

Follow Verrica Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRCA shares.

Notify only if

Insider Trading

Get notified when an Verrica Pharmaceuticals Inc. insider buys or sells VRCA shares.

Notify only if

News

Receive news related to Verrica Pharmaceuticals Inc.

Track Activities on VRCA